A Study of ARRY-438162 (MEK162) in Patients With Advanced Cancer

Clinical trial NCT00959127 · COMPLETED

Trial details

NCT number: NCT00959127
Sponsor: Array Biopharma, now a wholly owned subsidiary of Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors Advanced or Metastatic Biliary Cancer Metastatic Colorectal Cancer

Start date: 2009-08-01
Primary completion: 2013-01-01
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.